共 70 条
[1]
Roukos DH(2009)Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention Expert Rev Mol Diagn 9 1-6
[2]
Fujita T(2010)Relationship between the histological type of initial lesions and the risk for the development of remnant gastric cancers after gastrectomy for synchronous multiple gastric cancers World J Surg 34 296-302
[3]
Gotohda N(2009)Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer Ann Surg Oncol 16 795-798
[4]
Takahashi S(1994)Primary gastric lymphomas: a clinicopathologic study with literature review Surg Oncol 3 115-125
[5]
Nakagohri T(2004)Early-stage gastric cancer: a highly treatable disease Ann Surg Oncol 11 127-129
[6]
Konishi M(2002)Quality of surgery determinant for the outcome of patient with gastric cancer Ann Surg Oncol 9 828-830
[7]
Kinoshita T(2007)Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14 2691-2695
[8]
Roukos DH(2002)Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 9 220-221
[9]
Roukos DH(2006)Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer Expert Rev Anticancer Ther 6 931-939
[10]
Hottenrott C(2000)Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery Ann Surg Oncol 7 719-726